| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$198,559,401 |
|
|
|
Indirect Value
|
$175,231,488 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 21 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-06-15 |
4 |
B |
$9.86 |
$941,551 |
I/I |
95,492 |
16,603,524 |
2.25 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2020-12-31 |
4 |
S |
$1.90 |
$189,207 |
I/I |
(99,382) |
11,106,255 |
0 |
% |
|
| SRCL |
Stericycle Inc |
Chairman |
• • – |
2008-07-07 |
4 |
B |
$50.01 |
$5,000,940 |
I/I |
100,000 |
274,826 |
2.66 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2009-03-17 |
4 |
S |
$48.40 |
$4,839,670 |
D/D |
(100,000) |
2,535,618 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2009-03-17 |
4 |
A |
$7.71 |
$771,360 |
I/I |
100,000 |
189,267 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-12-07 |
5 |
GD |
$0.00 |
$0 |
D/D |
100,000 |
1,275,104 |
0 |
- |
|
| BIOL |
Biolase Inc |
10% Owner |
– – • |
2015-10-13 |
4 |
B |
$0.99 |
$99,000 |
I/I |
100,000 |
4,084,666 |
1.5 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-05-11 |
4 |
B |
$19.17 |
$1,932,762 |
I/I |
100,000 |
13,265,028 |
2.25 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-03-27 |
4 |
B |
$2.05 |
$204,580 |
I/I |
100,000 |
431,811 |
1.5 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-06-10 |
4 |
B |
$9.84 |
$984,000 |
I/I |
100,000 |
16,244,952 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-02-01 |
4 |
A |
$11.40 |
$1,140,000 |
I/I |
100,000 |
1,207,891 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-09-23 |
4 |
S |
$0.88 |
$87,600 |
I/I |
(100,000) |
3,912,604 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2022-01-13 |
4 |
B |
$4.03 |
$403,000 |
I/I |
100,000 |
18,663,916 |
2.25 |
% |
|
| BDSX |
Biodesix Inc |
|
• • • |
2022-12-12 |
4 |
B |
$1.48 |
$148,380 |
I/I |
100,000 |
20,052,112 |
0.01 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
10% Owner |
– – • |
2021-02-03 |
4 |
B |
$12.25 |
$1,242,150 |
I/I |
101,400 |
895,035 |
1.5 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-03-27 |
4 |
B |
$8.09 |
$824,881 |
I/I |
101,963 |
14,101,928 |
2.25 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-04 |
4 |
S |
$1.99 |
$203,153 |
I/I |
(102,000) |
11,004,255 |
0 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-05 |
4 |
B |
$4.50 |
$525,000 |
D/D |
110,000 |
3,200,890 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-06-07 |
4 |
B |
$2.56 |
$281,072 |
D/D |
110,000 |
4,562,864 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2013-08-20 |
4 |
B |
$1.45 |
$159,518 |
D/D |
110,005 |
7,064,149 |
2.45 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-03-21 |
4 |
B |
$2.32 |
$258,275 |
I/I |
111,407 |
111,407 |
1.5 |
- |
|
| BIOL |
Biolase Inc |
10% Owner |
– – • |
2015-10-12 |
4 |
B |
$1.03 |
$118,244 |
I/I |
114,800 |
14,800 |
1.5 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-06-03 |
4 |
B |
$2.55 |
$293,482 |
D/D |
115,290 |
4,326,578 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2014-03-20 |
4 |
S |
$1.90 |
$219,435 |
D/D |
(115,492) |
6,803,900 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
|
• • • |
2022-11-16 |
4 |
S |
$1.26 |
$147,271 |
I/I |
(116,882) |
221,442 |
0 |
- |
|
634 Records found
|
|
Page 21 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
